Walking capacities in multiple sclerosis measured by global positioning system odometer

Multiple Sclerosis

Volumn 13, Issue 2, 2007, Pages 220-223

  Créange, Alain ^a   Serre, I ^b   Levasseur, M ^c   Audry, D ^d   Nineb, D ^a   Boerio D ^a   Moreau, T ^d   Maison, P ^a  

^a HENRI MONDOR HOSPITAL   (France)

^b CENTRE HOSPITALIER SUD FRANCILIEN   (France)

^c CENTRE HOSPITALIER   (France)

^d DIJON UNIVERSITY HOSPITAL   (France)

Author keywords

Ambulation; Multiple sclerosis; Odometer; Walking capacities

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; DIAGNOSTIC VALUE; EXPANDED DISABILITY STATUS SCALE; FEMALE; FOLLOW UP; GLOBAL POSITIONING SYSTEM; HUMAN; INTERMETHOD COMPARISON; MALE; MULTIPLE SCLEROSIS; STATISTICAL SIGNIFICANCE; WALKING DIFFICULTY; WALKING SPEED;

ADULT; DISABILITY EVALUATION; FEMALE; FOLLOW-UP STUDIES; GEOGRAPHIC INFORMATION SYSTEMS; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; REPRODUCIBILITY OF RESULTS; SATELLITE COMMUNICATIONS; SEVERITY OF ILLNESS INDEX; TELEMETRY; WALKING;

EID: 34247095083     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1177/1352458506070667     Document Type: Article

References (11)

1. Hobart JC, Riazi A, Lamping DL, Fitzpatrick R, Thompson AJ. Measuring the impact of MS on walking ability. The 12-Item MS Walking Scale (MSWS-12). Neurology 2003; 60: 31-36.
2. Kurtzke JF. Rating neurological impairment in multiple sclerosis: an Expanded Disability Status Scale (EDSS). Neurology 1983; 33: 1444-52.
3. Hoogervorst ELJ, van Winsen LML, Eikelenboom MJ, Kalkers NF, Uitdehaag BMJ, Polman CH. Comparisons of patient self-report, neurologic examination, and functional impairment in MS. Neurology 2001; 56: 934-37.
4. Sharrack B, Hughes RAC, Soudain S, Dunn G. The psychometric properties of clinical rating scales used in multiple sclerosis. Brain 1999; 122: 141-59.
5. Fischer JS, Jak AJ, Kniker JE, Rudick RA, Cutter G. Administration and scoring manual for the Multiple Sclerosis Functional Composite measure (MSFC). Demos, 1999.
6. Hauser SL, Dawson DM, Lehrich JR, Beal MF, Kevy SV, Propper RD et al. Intensive immunosuppression in progressive multiple sclerosis. A randomized, three-arm study of high-dose intravenous cyclophosphamide, plasma exchange, and ACTH. N Engl J Med 1983; 308: 173-80.
7. McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the Diagnosis of Multiple Sclerosis. Ann Neurol 2001; 50: 121-27.
8. Nasr MK, McCarthy RJ, Walker RA, Horrocks M. The role of pedometers in the assessment of intermittent claudication. Eur J Vasc Endovasc Surg 2002; 23: 317-20.
9. Melanson EL, Knoll JR, Bell ML, Donahoo WT, Hill JO, Nysse LJ et al. Commercially available pedometers: considerations for accurate step counting. Prev Med 2004; 39: 361-68.
10. Bassett DR Jr, Ainsworth BE, Leggett SR, Mathien JA, Hunter DC, Duncan GE. Accuracy of five electronic pedometers for measuring distance walked. Med Sci Sports Exerc 1996; 28: 1071-77.
11. Murtagh EM, Boreham CA, Murphy MH. Speed and exercise intensity of recreational walkers. Prev Med 2002; 35: 397-400.